Indefinite Delivery Contract SPE2D220D0088

Award Date 4/21/20
Last Date to Order 4/20/25
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is for the manufacture and distribution of pharmaceutical and medical supplies to various government healthcare agencies, including the Department of Defense (DoD), Department of Veterans Affairs (VA), Indian Health Service (IHS), and Bureau of Prisons. The prime contractor, Avkare LLC, is a for-profit limited liability company based in Pulaski, Tennessee that specializes in the distribution of generic medications, medical supplies, and laboratory testing materials...
The Indefinite Delivery Contract (IDC) SPE2D220D0089 was awarded by the Defense Logistics Agency (DLA) to Puracap Laboratories LLC, doing business as BLU Pharmaceuticals, a for-profit limited liability company that manufactures and distributes pharmaceuticals. The single-award IDC, with a ceiling value of $13,800,304.00 and a period of performance through April 2025, is intended to provide a national supply source for the DLA, Department of Veterans Affairs (VA), Indian Health Service, and...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Puracap Laboratories LLC, doing business as BLU Pharmaceuticals. The contract falls under the VA's Pharmaceuticals and Drugs (FSS-61-IB) schedule and has a ceiling value of $21,231,260. It was awarded on April 1, 2019 with an ultimate completion date of October 31, 2025. Through this FSS contract, Puracap Laboratories provides various pharmaceutical products to the VA,...
The Indefinite Delivery Contract (IDC) SPE2D220D0101 was awarded to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The $5,934,599.30 single-award contract was issued by the Defense Logistics Agency (DLA) to provide a national supply source for various pharmaceutical products, including generic medications such as cephalexin, prednisone, emtricitabine-tenofovir, primaquine phosphate, and sulfamethoxazole-trimethoprim. The contract has a base period of one...
The federal contract IDV award SPE2DU25D1038 is an Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,999,999, aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines,...
The federal contract IDV award SPE2D224D0005 is a single-award Indefinite Delivery Contract issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Golden State Medical Supply, Inc. The contract has a total ceiling value of $20,495,935.00 and a period of performance through April 3, 2029. Under this IDV, Golden State Medical Supply, Inc. will provide a variety of pharmaceutical products to the Department of Veterans Affairs...
This Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company, has a total ceiling value of $10,373,182.60. The contract is for the manufacture and distribution of various pharmaceutical and medical products, including generic medications such as cephalexin, prednisone, sulfamethoxazole-trimethoprim, and primaquine phosphate tablets, as well as medical equipment and supplies like urinalysis testing materials and...
The federal contract IDV award SPE2DU25D5140 is an Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has a total ceiling value of $4,999,999.00 and runs through December 31, 2036. The purpose of this IDC is to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Golden State Medical Supply, Inc. (GSMS), a for-profit manufacturer and distributor of pharmaceuticals and other medical products. The contract has a ceiling value of $4,547,341.50 and a period of performance ending on May 23, 2026. The IDC facilitates the provision of a wide range of pharmaceutical products to the Department of Defense (DoD), Department of Veterans Affairs (VA),...
The Indefinite Delivery Contract (IDC) SPE2D221D0125 is a single-award contract awarded to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and medical products based in Camarillo, California. The contract has a total ceiling value of $3,657,817.10 and a period of performance ending on October 13, 2025. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to provide a national supply source for various strengths of...

The federal contract IDV award SPE2D220D0088 is an Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Puracap Laboratories LLC, doing business as BLU Pharmaceuticals. The contract has a ceiling value of $1,020,032.00 and a period of performance through April 20, 2025.

The purpose of this IDC is to establish a national supply source for the procurement of Azithromycin Suspension 200MG/5ML 15ML and 200MG/5MG 30ML bottles by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through the DLA and VA prime vendor programs. This is a commercial item procurement under FAR Part 12, with no set-asides used. The initial solicitation was posted in September 2019, resulting in the single-award IDC issued to Puracap Laboratories in April 2020. Puracap Laboratories has also received prior federal contract awards from the DLA, VA, and HHS to supply medications including doxycycline hyclate, simvastatin, and azithromycin, demonstrating their proven capabilities in supporting federal health programs.

Generated 8/28/24, 10:56 AM